These findings suggest that D2-like stimulation could increase mineralization, which would make the D2-like DR stimulation in osteoblast an interesting therapeutic target against bone loss specifically in RA, but the increase in MIF and RANKL also suggest an effect on osteoclasts that should be considered. The gene discussed is MIF; the disease is rheumatoid arthritis.